Thoth CEO Presents at DiscoveryLab: Showcasing AI-MedCraft and the Future of AI-Driven Drug Discovery

Dr. Khaled Barakat, CEO of Thoth Biosimulations, delivered a compelling presentation at DiscoveryLab, an innovation showcase that brings together visionaries in science, technology, and entrepreneurship.

n his talk, Dr. Barakat introduced AI-MedCraft, Thoth’s flagship generative AI platform built to design small-molecule drugs through true multi-objective optimization. He shared real-world case studies demonstrating how the platform accelerates lead generation, enhances drug-likeness, and intelligently explores vast chemical spaces to overcome traditional drug discovery limitations.

The presentation drew strong interest from industry leaders, investors, and academic partners — reinforcing Thoth’s growing reputation as a cutting-edge force in the life sciences and biotech sectors.

“We’re not just accelerating drug discovery — we’re reimagining it,” said Dr. Barakat.

Stay tuned as we continue to break boundaries in AI-powered precision therapeutics.